10/29/2019 | Intavis AG | News

CEM Corporation acquires key assets of Intavis Bioanalytical Instruments

Matthews, N.C. October 25th, 2019 – CEM Corporation today announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, in-situ hybridization and particularly in the field of peptide synthesis.

Further information

For more information, contact CEM Corporation

Jonathan M. Collins
Vice President Business Development
jon.collins@cem.com

Source:
https://intavis.com/cem-corporation-acquires-key-assets-of-intavis-bioanalytical-instruments/